Edition:
United States

CAS Medical Systems Inc (CASM.OQ)

CASM.OQ on NASDAQ Stock Exchange Capital Market

0.97USD
4:00pm EDT
Change (% chg)

$-0.01 (-1.02%)
Prev Close
$0.98
Open
$0.97
Day's High
$0.97
Day's Low
$0.97
Volume
403
Avg. Vol
13,866
52-wk High
$2.15
52-wk Low
$0.80

Latest Key Developments (Source: Significant Developments)

Casmed reports Q1 loss per share of $0.08
Wednesday, 3 May 2017 08:00am EDT 

May 3 (Reuters) - Cas Medical Systems Inc :Casmed reports first-quarter 2017 financial results.Q1 loss per share $0.08.Q1 sales $5.2 million versus $5.5 million.Sees 2017 total fore-sight sales to increase in mid-single-digit percentages.Sees 2017 total fore-sight disposable sensor sales to increase approximately 10 pct.Sees 2017 U.S. Fore-Sight sensor sales to increase in mid-teens percentages.Sees 2017 U.S. Monitor placements to increase in mid-teens percentages.  Full Article

Thomas Patton reports 5.6 pct stake in CAS Medical Systems Inc
Tuesday, 4 Apr 2017 07:35am EDT 

Cas Medical Systems Inc :Thomas M. Patton reports 5.6 percent stake in CAS Medical Systems Inc, as of March 10, 2017 - SEC filing.  Full Article

CAS Medical Q4 loss per share $0.07
Thursday, 9 Mar 2017 08:00am EST 

CAS Medical Systems Inc : Casmed reports 2016 fourth-quarter and full-year financial results . Q4 loss per share $0.07 . Q4 sales rose 3 percent to $5.5 million .CAS Medical Systems Inc - expecting 2017 total fore-sight sales increasing in mid-teen percentages.  Full Article

Norman Pessin reports 5 pct stake in CAS Medical Systems
Wednesday, 4 Jan 2017 10:51am EST 

Cas Medical Systems Inc : Norman Pessin reports 5.0 percent stake in CAS Medical Systems Inc as of Jan 3 - sec filing .Norman Pessin had previously reported a stake of 4.0 percent in CAS Medical Systems Inc as of Nov 6, 2015.  Full Article

CASMED Q2 loss per share $0.08
Thursday, 4 Aug 2016 08:00am EDT 

Cas Medical Systems Inc : Q2 loss per share $0.08 . Q2 sales rose 18 percent to $5.5 million . Affirming expectation to ship a total of 400 fore-sight cerebral oximeters this year .Also on track to achieve our 2016 growth objective of fore-sight sales exceeding 20 percent.  Full Article

CAS Medical Systems says entered loan agreement with Solar Capital
Tuesday, 5 Jul 2016 06:45am EDT 

CAS Medical Systems Inc : Says entered into a loan and security agreement with Solar Capital Ltd - SEC filing . Says lenders are providing company with a 48-month secured term loan in the amount of $8 million . Says lenders are providing company with revolving loan in the maximum amount of $2.5 million .Says revolver expires on July 1, 2018 and the term loan matures on July 1, 2020.  Full Article

CAS Medical Systems Inc sells neonatal intensive care disposables product line
Tuesday, 29 Mar 2016 04:20pm EDT 

CAS Medical Systems Inc:Says sale of assets related to its neonatal intensive care disposables product line to Trinity Medical Devices Inc.Sale is in the amount of $3.35 million.  Full Article

CAS Medical Systems, Inc sells vital signs monitoring product line to Zoe Medical Inc
Thursday, 29 Oct 2015 08:00am EDT 

CAS Medical Systems, Inc:Casmed sells vital signs monitoring line, tightens focus on fore-sight cerebral oximetry business.Says announces the sale of assets related to its 740 select® vital signs monitoring product line to zoe medical, inc.Zoe medical will take assignment of casmed's vital signs monitor distribution organization after a transition period.  Full Article

More From Around the Web

BRIEF-Thomas Patton reports 5.6 pct stake in CAS Medical Systems Inc

* Thomas M. Patton reports 5.6 percent stake in CAS Medical Systems Inc, as of March 10, 2017 - SEC filing Source text for Eikon: (http://bit.ly/2oUoICU) Further company coverage: